SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008161-04-000008
Filing Date
2004-03-26
Accepted
2004-03-26 16:51:47
Documents
1
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3735
  Complete submission text file 0001008161-04-000008.txt   5630
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 137 SPRUCE CIRCLE N BANNEGAT NJ 08005
Business Address US LABORATORIES INC 7895 CONVOY CT SUITE 18 SAN DIEGO CA 92111
PETERSON ROBERT E (Reporting) CIK: 0001078848 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13441 | Film No.: 04693509